Skip to content
Results research

Concall Intelligence

Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search transcript evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.

Open reported results
Matching calls
2
After selected filters
Loaded now
2
Page 1 of 1
Summaries ready
2
Source-linked evidence in this page
Tracked companies
0
Watchlist or portfolio matches

Management evidence

Generated 21 Oct, 3:59 am IST · click a summary to inspect source-linked evidence for this results quarter.

Clear filters
CompanyCall and sourcesReported resultManagement outlookEvidence-led conclusionReview
ANANDRATHI
Anand Rathi Wealth Limited
Financial Services · Small
Sept 2026
19 Oct 2026
Bad
2/100
Bullish outlook
No comparable prior call
No measurable guidance

The company continues its streak of >20% YoY PAT growth, demonstrating market-agnostic performance. Strong net flows and client acquisition, coupled with strategic expansions into GIFT City and a planned AMC, support the long-term growth thesis despite market volatility.

Evidence summary ready
POONAWALLA
Poonawalla Fincorp Limited
Financial Services · Small
Sept 2026
19 Oct 2026
Excellent
85/100
Optimistic outlook
Broadly unchanged
No measurable guidance

The company demonstrates consistent execution on its strategy of profitable growth, margin expansion, and asset quality improvement. Structural gains from AI/digital adoption, new product traction, and cross-sell are reinforcing a compounding earnings engine, despite ongoing investments.

Evidence summary ready
Method: Deterministic quarterly-result score from reported growth, margin direction and operating leverage. Derived only from extracted, source-linked management evidence. Pending is shown when evidence is insufficient. Measurable claims are separated from general commentary and retain outcome status when later evidence exists. Management outlook and colours describe extracted commentary evidence; they are not buy or sell labels.